Industries > Pharma > Transfection Reagent and Equipment Market Forecast 2020-2030

Transfection Reagent and Equipment Market Forecast 2020-2030

Forecasts and Analysis by Method, by Application, by Product and Geography, with Profiles of Leading Companies

PAGES: 171
SUBMARKET: Medical Devices

WOOCS 2.2.1
SKU: PHA0699 Categories: , Tag:

According to the report published by Visiongain, the Transfection Reagent and Equipment market is estimated to be valued at approximately USD xx million in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. Transfection is the mechanism by which nuclear acids are inserted by non-viral approaches into eukaryotic cells. This gene transfer technology allows gene roles and protein expression to be studied in a cellular setting utilizing different chemical or physical approaches. Transfection uses have been significantly expanded by the design of reporter gene systems and selection procedures for safe preservation and expression of transfected DNA. Assay based technology provides the basis for the study of mammalian promoters and enhancer sequences, transacting proteins, such as transcription factors, mRNA processing, and protein, along with an extensive range of transfectional reagents. Development of recombinant technology & proteomics and the rising use by academic researchers of transfecting technology are some of the major developments that fuel market development. It is also planned that new reagents will be added to extend the use of transfection in various applications.

Transfection is one of the main research projects that lead to synthetic genetics studies. Transfections can lead to the development of abnormal cells and unstable morphologies, but the mechanism can also be used to research the composition of genetic makeup and, through a deliberate invasion, change cell structures. Transfection has a crucial role in biomonitoring through the facilitation of research analyzes and bio-authenticity studies for regulatory approval of biopharmaceuticals. It innovation is therefore likely to be seeing both market and sales growth with the growing popularity of biopharmaceutical goods. Moreover, recently, the biopharmaceutical sector has seen a major patent cliff, with a patent expiration for several blockbuster biologics. As a result, many businesses have started to invest in the development of biosimilar biologic alternative products to address the risk of income loss. Therefore, by increasing the adoption rate of transfection software, the patent cliff risk has greatly benefited the business.

Why you should buy Transfection Reagent and Equipment Market Forecast 2020-2030

Transfection Methods Such As Laserfection Or Optoinjection Are Estimated To Boost The Growth Of The Equipment Segment.
Most of the transfection reagents include transfection kits for stem cells, transfection kits for siRNA, transfection buffers and optimisation kits for transfections. Various transfection methods involve the use of different reagents and thereby produce substantial revenue for the product. In terms of revenues, the reagents sector dominated the market. According to rising market acceptance levels of these reagents, this segment is expected to become important over the forecast period. Electroportation and electro fusion systems include transfection equipment. The volume of genomics-based research & development projects and the introduction of easy to use products like portable are rapidly rising. Owing to presence of expensive laser-based equipment used for different transfection methods such as laserfection or optoinjection are estimated to boost the growth of the equipment segment.

The Liposome Sector Is Expected To Post Notable CAGR During The Forecast Period
Livosomal transfer and particulate bombardment were closely followed in 2019 by electric company as the leading revenue share. Wide portfolios offered by large and emerging players for a range of electroporation solutions stimulate segment growth. In addition, the segment growth increases with a number of advantages, such as ease of use, variability and speed. The liposome sector is expected to post notable CAGR during the forecast period, with considerable participation in 2016. This method will likely be supported by a continued development of lipofection for increased in-vivo transfection efficiency.

The Income Generated From The Transfection Applications Is Projected To Significantly Increase, Contributing To Success On The Sector
In view of the increasing process volumes and the availability of a relatively large number of R&D projects, the income generated from the transfection applications is projected to significantly increase, contributing to success on the sector. Transfection reagents and devices studied are used in gene expression experiments, in the manufacture of proteins, in transgenic template development, in medicinal delivery, in biomedical research and in cancer research. The most prominent application segment in 2019 was gene expression studies. Expanding the genomic data pool and increasing emphasis on genomic information translation in clinical workflows lead to a significant share. Presence of a substantial number of ongoing research projects that aim at in-depth investigation of key mechanism, which underlie chromosomal anomalies, is also supplementing the growth of the segment.

North America was the market leader in 2019
Due to the presence of established biopharmaceuticals and genomics industries in the region, North America was the market leader in 2019. Among biological, cytological and oncological research institutions, there has been a heavy use of transfection technologies. Also leading to the development of the regional market is the existence of influential firms offering a variety of solutions to different end-useers in the area. The most rapid growth in the forecast period is expected in the Asia-Pacific region. Significant growth in the number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, and rising awareness regarding cytological and proteomic expressions are some of the key trends driving the regional market.

What is the future of the Transfection Reagent and Equipment market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.

We guarantee in this 171 page report you will receive the following key information

• View Transfection Reagent and Equipment market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Transfection Reagent and Equipment revenue forecast
– Transfection Reagent and Equipment connections forecast

• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Transfection Reagent and Equipment market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Transfection Reagent and Equipment sector

• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Transfection Reagent and Equipment industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Transfection Reagent and Equipment submarkets with individual forecasts and analysis from 2020-2030.
– Method submarket forecast 2020-2030
– Application submarket forecast 2020-2030
– Product submarket forecast 2020-2030

• Learn about the market prospects for the leading Transfection Reagent and Equipment market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Transfection Reagent and Equipment revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.

– Method Revenue Forecast 2020-2030
Electroporation revenue forecast 2020-2030
Liposomes revenue forecast 2020-2030
Particle Bombardment revenue forecast 2020-2030
Microinjection revenue forecast 2020-2030
Adenoviral Vectors revenue forecast 2020-2030
Direct Microinjection revenue forecast 2020-2030
Calcium phosphate revenue forecast 2020-2030
DEAE – dextran revenue forecast 2020-2030
Magnetic Beads revenue forecast 2020-2030
Activated Dendrimers revenue forecast 2020-2030
Laserfection revenue forecast 2020-2030
Other Methods revenue forecast 2020-2030

– Application Revenue Forecast 2020-2030
Gene Expression Studies revenue forecast 2020-2030
Protein Production revenue forecast 2020-2030
Transgenic Models revenue forecast 2020-2030
Therapeutic Delivery revenue forecast 2020-2030
Cancer Research revenue forecast 2020-2030
Biomedical Research revenue forecast 2020-2030

– Product Revenue Forecast 2020-2030
Reagents revenue forecast 2020-2030
Equipment revenue forecast 2020-2030
Other Products revenue forecast 2020-2030

• Understand the prospects for the 4 regional and the leading 12 national Transfection Reagent and Equipment markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Transfection Reagent and Equipment companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts

• Explore the factors affecting Transfection Reagent and Equipment product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry

• Identify who the leading companies are in the Transfection Reagent and Equipment industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Transfection Reagent and Equipment companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.

The foreign demand for transfection reactives and equipment is projected to exhibit positive rate of growth in the next few years, largely due to recent developments in transfection engineering and the heavy effect on research and development activities on this sector by pharmaceutical and biotechnology organizations. The global reaction and equipment market also benefits from the newly established high-value alliances and partnerships, particularly between large pharmaceutical names and institutes of research, to boost drug discovery rates. The global demand for synthetic genes has seen and will probably continue to grow at a strong rate in the recent past. The study and growth efforts to combat cancer, an illness already highly prevalent in all countries, represent a significant part of this market.

Biotechnology firms, pharmaceutical companies, research institutes and educational institutions are the global market leading end users of transfection reagents and supplies. Viral, physical and biochemical are the main methods of transfection that this market can be segmented on. The video market would likely show a very positive growth trend in the next few years.

Leading Companies in the Global Transfection Reagent and Equipment Market
Merck KgaA
Thermo Fisher Scientific Inc
Promega Corporation
Mirus Bio LLC
EMD Millipore
Bio-Rad Laboratories Inc.
OriGene Technologies Inc
Lonza AG
F. Hoffmann-La Roche Ltd
Maxcyte, Inc.

Discover Information found nowhere else in this independent assessment of the Transfection Reagent and Equipment market
The Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis By Method, By Application, By Product and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Transfection Reagent and Equipment sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.

With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.

What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030.

How the Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis By Method, By Application, By Product and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Transfection Reagent and Equipment market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.

Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Transfection Reagent and Equipment sector and find out what its future market prospects are.

To access the data contained in this document please email

Buy our report today Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis by Method, by Application, by Product and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Transfection Reagent and Equipment Market Forecast 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Transfection Reagent and Equipment Market Forecast 2020-2030

Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022


Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022


Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022


Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022